Company Search:
Advanced Search
Sponsored Links
Novartis AG - ADR Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis AG with three other companies in this sector in the United States: Roche Holding Aktiengesellschaft (2016 sales of $51.16 billion of which 77% was Pharmaceuticals), Pfizer Inc. ($52.82 billion of which 55% was Operating Segment-Global Innovative Phar), and Bayer AG ($51.62 billion of which 35% was Pharmaceuticals & Biological Products).

Sales Analysis. Novartis AG reported sales of $49.39 billion for the year ending December of 2016. This represents a decrease of 1.9% versus 2015, when the company's sales were $50.36 billion. Contributing to the drop in overall sales was the 40.8% decline in Alcon, from $9.81 billion to $5.81 billion. . However, these declines were partially offset by the increase in sales of Innovative Medicines (up 7.0% to $32.56 billion) and Sandoz (up 10.8% to $10.14 billion) .
  Stock Performance Chart for Novartis AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 86.94
(Figures in U.S. Dollars)
1 Week 0.3%   13 Weeks 4.8%  
4 Weeks 1.4%   52 Weeks 23.1%  
Novartis AG - ADR Key Data:
  Ticker: NVS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 49,386,019,063
(Year Ending Jan 2017).
Employees: 118,393
  Currency: U.S. Dollars Market Cap: 202,338,919,778
  Fiscal Yr Ends: December Shares Outstanding: 2,327,339,772
  Share Type: Namenaktie Closely Held Shares: 88,340,769
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.